Financhill
Back

Standard BioTools Stock Predictions

Standard BioTools Stock Forecast

  • Is Standard BioTools Stock Undervalued?
    The current Standard BioTools [LAB] share price is $1.62. The Score for LAB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • LAB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Standard BioTools Stock Go Up Next Year?

Data Unavailable

Standard BioTools Stock Rating

Data Unavailable

Standard BioTools Stock Price History

Is LAB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LAB is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
standardbio.com

52-Week Data

52-Week High:
3.04
52-Week Low:
1.21

Prediction Charts

Market Cap:
603.06M
Price in USD:
1.62
Volume:
1.96M
Beta:
1.68

Technical Analysis

SMA50:
1.89
SMA100:
1.92
SMA200:
2.20
52-Wk Change:
-29.57%

Stock Predictions

  • Is Standard BioTools stock public?
    Yes, Standard BioTools is a publicly traded company.
  • What is the Standard BioTools stock quote today?
    The Standard BioTools stock price is 1.62 USD today.
  • How to buy Standard BioTools stock online?
    You can buy Standard BioTools shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-4 2.00 2.10 2.11 1.99
Nov-5 2.08 2.11 2.23 2.06
Nov-6 2.24 2.26 2.27 2.10
Nov-7 2.25 2.18 2.32 2.16
Nov-8 2.18 2.15 2.21 2.12
Nov-11 2.21 2.24 2.26 2.14
Nov-12 2.20 2.06 2.22 2.03
Nov-13 2.07 1.85 2.10 1.85
Nov-14 1.81 1.70 1.84 1.67
Nov-15 1.72 1.58 1.73 1.57
Nov-18 1.57 1.50 1.58 1.48
Nov-19 1.49 1.51 1.56 1.46
Nov-20 1.51 1.61 1.69 1.48
Nov-21 1.62 1.62 1.67 1.56

Standard BioTools Earnings

Data Unavailable

Standard BioTools Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and an increase next year of $0.06 per share.

* Standard BioTools stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.